Results from the EXPEDITE study of Remodulin® induction prior to Orenitram® therapy to be presented at ATS
Baseline patient data from the TETON studies of Tyvaso® Inhalation Solution in. | April 18, 2023
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2022 Annual Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Pulmonary Fibrosis Foundation Announces Sponsorship by United Therapeutics
News provided by
Share this article
CHICAGO, Jan. 14, 2021 /PRNewswire/ The
Pulmonary Fibrosis Foundation (PFF), the nation s leading pulmonary fibrosis (PF) education and advocacy organization, has announced United Therapeutics sponsorship of the PFF Registry, a research resource that tracks clinical data, blood samples and patient-reported outcomes from individuals living with PF nationwide.
United Therapeutics has joined the Pulmonary Fibrosis Foundation (PFF) as a sponsor of the PFF Registry, a research resource that tracks clinical data, blood samples, and patient-reported outcomes from individuals living with pulmonary fibrosis nationwide.
United Therapeutics is a leading biotechnology company with a mission to develop treatments for rare diseases, including pulmonary hypertension (PH) and idiopathic pulmonary fibrosis (IPF). The sponsorship will help researchers working to address the unmet